Description: The SOA is releasing this brief report which summarizes the results of the latest National Health Expenditure (NHE) data released by the U.S. Government. This report highlights some of the key elements of the 2018 NHE data and compares them to prior year data and projections.

Description: This tool created graphs of Google's mobility Data. This version of the tool contains global, country-level data through July 31, 2020

Description: An update of selected key graphs from the Key Statistics section of previous COVID-19 briefs.

Description: In this report, we explore the impact of clustering using the Medical Expenditure Panel Study (MEPS) data for children (aged 5 to 17) to build a bridge between oral health and overall health using dental and medical expenditures. We include social determinants of health as cluster input variables using the Partitioning around Medoids (PAM) method to identify children and their families who could potentially benefit from population health management related to oral health.

Description: Can Direct-to-Provider Contracting Achieve Value-Based Care for Employer-Sponsored Plans? Direct-to-provider contracting is a strategy in which a self-insured entity negotiates a contract directly with a provider of healthcare services rather than through a third-party administrator (TPA), often with the goal of driving value-based care. This article discusses the considerations for employers and providers with direct-to-provider contracting.

Description: This excerpt is from a presentation done by a panelist at the Intercompany Long-Term Care Insurance Conference Association closing session in Chicago in March. We can never fully express our thanks to the Alzheimer’s Association and Tom Doyle for the courage to share his moving story and optimism for the future.

Description: Q&A with President Life & Health US. Swiss Re. Neil Sprackling.

Description: Life insurance products have evolved over time from the early mutual aid societies paying benefits when members died to comprehensive products covering a range of financial needs over an individual’s lifecycle. While some life insurance benefit riders have been offered for decades and are well-established, recent years have seen a number of accelerated benefit riders being introduced by carriers for a growing range of covered triggers. Join us as we discuss these acceleration and extended benefit riders, trends and innovations in the space, and discuss challenges and actuarial considerations in designing, pricing, and modelling them. We will also explore issues carriers have experienced, how to consider the interactions between these benefits and the underlying mortality coverage, reinsurance considerations, and more!

Description: This session will provide an overview of the challenges found in understanding and managing the medical drug benefit based on standard claims data. Participants will learn what makes coding medical drugs challenging and how to navigate some of the pitfalls when conducting analyses on this important segment of utilization and cost trend.

Description: Session 1G: Rethinking Catastrophic Claims - Strategies for Sustainable Stop-Loss Pricing